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Limted proteolysis of caldesmon has been used in studying the structure-function relationship of this protein. 
Digestion with a-chymotrypsin yields three major fragments of 110, 80 and 40 kDa. Only the 40 kDa frag- 
ment preserves functional properties of the parent molecule: it binds to F-actin, causes inhibition of acto- 
myosin ATPase and binds to calmodulin in a Ca z+-dependent manner. Its further degradation produces 
an 18 kDa polypeptide that also retains all these properties. Neither F-actin nor calmodulin binding induces 
dramatic changes in susceptibility to chymotryptic leavage and the sites of cleavage of caldesmon. 
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1. INTRODUCTION 
Caldesmon is a major actin- and calmodulin- 
binding protein of smooth muscle [l]. It is located 
in thin filaments and seems to play a role of 
regulator of actin-myosin interaction, complemen- 
tary to myosin phosphorylation [2]. In vitro, its 
binding to F-actin causes inhibition of actin- 
activated ATPase activity of smooth and skeletal 
muscle myosin that can be released by calmodulin 
in the presence of Ca2+ [3-51. 
The aim of the present work was to provide 
some insight into the structural and functional 
relationships of caldesmon. With the use of limited 
proteolysis of caldesmon by cr-chymotrypsin we 
have identified the functional domain of this pro- 
tein responsible for actin and calmodulin binding 
and involved in the inhibition of actomyosin 
ATPase activity. Preliminary reports of this work 
have been presented [6,7]. 
2. MATERIALS AND METHODS 
Caldesmon was prepared from fresh chicken giz- 
zard muscle according to Bretscher [8]. Rabbit 
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skeletal muscle actin and chicken gizzard 
tropomyosin were obtained as described in [9]. 
Rabbit skeletal muscle myosin was obtained ac- 
cording to [lo]. Calmodulin was prepared from 
bovine brain as in [ 111. The purity of all these pro- 
teins was checked by SDS-polyacrylamide gel 
electrophoresis. 
Digestion of caldesmon with w-chymotrypsin 
was performed at 1: 1000 weight ratio of enzyme to 
substrate in a buffer solution containing 75 mM 
KCl, 20 mM imidazole-HCl (pH 7.0), 1 mM @- 
mercaptoethanol and 10 mM NaN3 at 30°C. The 
reaction was terminated by addition of 
phenylmethanesulfonyl fluoride (PMSF) (10 x the 
weight of chymotrypsin). 
ATPase activity of rabbit skeletal muscle ac- 
tomyosin (reconstituted from 30 pg/ml F-actin 
and 120 pg/ml myosin) was assayed in the presence 
of chicken gizzard tropomyosin (at a 2: 7 molar 
ratio to actin monomer) and various amounts of 
intact caldesmon or its fragments in medium con- 
taining 50 mM KCl, 2 mM MgCL, 2 mM ATP, 
0.1 mM EGTA and 10 mM imidazole-HCl (pH 
7.0) at 30°C. The amount of Pi liberated was 
measured as in [12]. 
SDS-polyacrylamide gel electrophoresis was car- 
ried out on 7%20% gradient slab gel according to 
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Laemmli [ 131. For calculation of molecular mass, 
the following marker proteins were used: rabbit 
skeletal muscle myosin heavy chain (205 kDa) and 
light chains (26, 18 and 16 kDa), phosphorylase b 
(94 kDa), bovine serum albumin (66 kDa), actin 
(42 kDa), troponin I (21 kDa) and calmodulin 
(16.7 kDa). 
Protein concentration was determined by 
measuring UV light absorbance with the following 
values of extinction coefficients and molecular 
mass: caldesmon, &76 = 0.30, 140 kDa [8]; G- 
actin, E290 = 0.63 [14], 42 kDa; myosin, E279 = 
0.54, 470 kDa [15]; tropomyosin, E278 = 0.29, 
72 kDa [16]; calmodulin, &78 = 0.20, 16.7 kDa 
[17]; or by the method of Lowry et al. [18]. 80. 
3. RESULTS 60- 
In the initial experiments caldesmon was 
digested with various concentrations of CY- 
chymotrypsin for different times. It was found 
that a ratio of cu-chymotrypsin to caldesmon of 
1: 1000 (w/w) was the most suitable as this allowed 
the observation of intermediate polypeptides. A 
representative digestion pattern is shown in fig.1. 
After 1 min digestion three major fragments of 
110, 80 and 40 kDa and several minor fragments 
of 54, 29, 23, 18 kDa and sometimes a 16 kDa 
fragment of caldesmon are seen. The latter seem to 
derive from the major fragments since their 
amounts gradually increase during further diges- 
tion with a parallel decrease in the amounts of the 
major fragments (fig.1). The 54 kDa fragment 
seems to be a degradation product of the 110 kDa 
polypeptide, and the 23 and 18 kDa fragments 
presumably derive from the 40 kDa polypeptide. 
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Parallel investigation of the effects of intact and 
digested caldesmon on the actomyosin ATPase ac- 
tivity (in the presence of chicken gizzard 
tropomyosin) revealed that the extent of inhibition 
of the ATPase by the chymotryptic digest of 
caldesmon is comparable to that by the intact pro- 
tein (fig.1). Thus, it is apparent that some of the 
fragments of caldesmon retain the ability of the 
parent molecule to inhibit the actomyosin ATPase. 
Fig. 1. Effect of chymotryptic fragmentation of 
caldesmon on its ability to inhibit actomyosin ATPase 
activity. Digestion of caldesmon with cy-chymotrypsin 
was performed at a weight ratio of protease to substrate 
of 1: 1006 under the conditions described in section 2. 
Samples of the reaction mixture withdrawn during 
digestion were analysed by SDS-polyacrylamide gel 
electrophoresis and examined in ATPase assay. 
Actomyosin ATPase activity was assayed as described in 
section 2 at a 1: 1.5 weight ratio of intact or digested 
F-Actin or calmodulin binding as well as the 
presence of tropomyosin did not significantly af- 
fect the susceptibility of caldesmon to chymotryp- 
tic attack and the sites of its cleavage (not shown). 
This indicates that these proteins do not induce ex- 
tensive conformational changes in the structure of 
caldesmon. Digestion of F-actin-caldesmon com- 
plex with cY-chymotrypsin and subsequent 
ultracentrifugation of the digest revealed that the 
40, 23 and 18 kDa fragments of caldesmon co- 
sediment with F-actin (fig.2). The pellet fraction, 
but not the supernatant which contains mainly the 
high-molecular-mass fragments (110 and 80 kDa), 
caused the inhibition of actomyosin ATPase in the 
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presence of chicken gizzard tropomyosin in- 
dicating that only those caldesmon fragments 
which bind to F-actin can affect the actomyosin 
ATPase. There was no evidence of significant 
degradation of F-actin alone under identical condi- 
tions of chymotryptic digestion, only a thin band 
below actin derived from this protein (fig.2). 
To identify calmodulin-binding fragment(s) of 
caldesmon, the chymotryptic digest of the latter 
protein was applied on an affinity column of 
calmodulin-Sepharose 4B. SDS-polyacrylamide gel 
electrophoresis showed that the fraction of 
polypeptides specifically bound to the calmodulin 
column and eluted with 2 mM EGTA contained 
the 40, 23 and 18 kDa polypeptides, the same as 
those binding to F-actin. The nonretarded fraction 
contained the high-molecular-mass polypeptides 
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Frg.2. Binding of caldesmon fragments to F-actin and 
calmodulin and their effects on actomyosin ATPase 
activity. To identify F-actin-binding fragments of 
caldesmon an excess of intact caldesmon was mixed with 
F-actin (at 1 mg/ml) in a buffer containing 100 mM 
KCI, 10 mM imidazole (pH 7.0), 0.1 mM CaCl2, 5 mM 
NaNs and 1 mM ,&mercaptoethanol and ultracentri- 
fuged for 3 h at 100000 x g. Pellet resuspended in the 
same buffer was treated with ru-chymotrypsin (6 min at 
a 1: 1000 weight ratio of protease to substrate). The 
digest was ultracentrifuged for 3 h at 100000 x g. 
Dissolved pellet and supernatant were analysed by SDS- 
polyacrylamide gel electrophoresis and examined in 
ATPase assay at a weight ratio of each fraction to actin 
of 1: 1.5. To identify calmodulin-binding fragments 
caldesmon was digested with cu-chymotrypsin (6 min at 
1: 1000 weight ratio of protease to substrate). The digest 
was applied on a calmodulin-Sepharose 4B column (1.5 
x 26 cm) equilibrated with buffer containing 0.2 mM 
CaCl2, 50 mM NaCl, 40 mM Tris-HCl (pH 7.5), 10 mM 
NaNs and 1 mM &mercaptoethanol. The non-retarded 
and EGTA (2 mM)-eluted fractions were analysed by 
SDS-polyacrylamide gel electrophoresis and examined in 
ATPase assay at a 1: 1.5 (w/w) ratio of each fraction or 
intact caldesmon to actin. (a) Intact caldesmon, (b) 
digested caldesmon, (c) fragments of caldesmon that do 
not bind to F-actin, (d) F-actin-binding fragments of 
caldesmon, (e) caldesmon fragments that do not bind to 
calmodulin, (f) calmodulin-binding fragments of 
caldesmon. CD, caldesmon; A, actin; A’, actin degrada- 
tion product. 
110 and 80 kDa, and several minor fragments. 
This fraction did not affect the ATPase activity of 
actomyosin (fig.2). 
The fraction containing calmodulin-binding 
polypeptides of caldesmon was applied to an Affi- 
Gel blue column and eluted with a linear 0- 1.8 M 
NaCl gradient. The electrophoretically pure 18 and 
40 kDa fragments of caldesmon were selected 
from the leading and trailing part of the protein 
peak, respectively (fig.3). As shown in fig.4 both 
fragments had an ability to inhibit the actomyosin 
ATPase activity in the presence of smooth muscle 
tropomyosin. The extent of inhibition was roughly 
the same as that by intact caldesmon. Digestion of 
the isolated 40 kDa polypeptide with chymotrypsin 
confirmed our presumption that the 18 kDa (as 
well as the 23 kDa) fragment is its degradation 
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Fig.3. Purification of the 40 and 19 kDa fragments of 
caldesmon on Affi-Gel blue column, The fraction of 
caldesmon fragments eluted from calmodulin-Sepharose 
4B column with EGTA (see legend to fig.2) was applied 
to an Affi-Gel blue column (2 x 20 cm) equilibrated with 
20 mM KsHPOd, 1 mM EGTA, 1 mM EDTA, 1 mM 
dithiothreitol (DTT) and 0.02% NaNr. The proteins 
were eluted with a O-l -8 M NaCl gradient. Pure 40 and 
18 kDa fragments were selected by SDS-polyacrylamide 
gel electrophoresis (see inset) and pooled as indicated. 
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Fig.4. Effect of 40 and 18 kDa fragments of caldesmon 
on actomyosin ATPase activity. ATPase activity was 
assayed as described in section 2. Amounts of the 
40 kDa (o), 18 kDa (A) fragment and intact caidesmon 
(x) as indicated on the abscissa. 
w - 40 kD& 
Fig.5 Chymotryptic digestion of the 40 kDa fragment 
of caldesmon. Digestion was performed at a weight ratio 
of protease to substrate of 1: 1000 under the conditions 
described in section 2. The digestion pattern was 
examined by SDS-polyacrylamide gel electrophoresis. 
product (fig.5). Thus, it can be concluded that 
caldesmon contains a functional domain that is 
present in the 18 kDa fragment of its polypeptide 
chain ~representing less than I3010 of the molecular 
mass of the parent molecule). This domain is 
responsible for the binding of caldesmon to F-actin 
that induces the inhibition of actomyosin ATPase 
activity, and for the Ca’+-dependent binding to 
calmoddin. 
4. DISCUSSION 
CaIdesmon seems to pIay an important role in 
regulation of smooth muscle and probably non- 
muscle motile processes 1191. The inhibition of 
actin-myosin interaction by this actin-binding pro- 
tein can be regulated by Ca2+ either via calcium- 
dependent binding to calmodulin [2,3] or/and by 
its Ca2+- and calmoduhn-dependent phosphoryla- 
tion 14,201. 
We report here the results of studies on limited 
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proteolysis of chicken gizzard caldesmon as a 
probe of the structure-function relations of this 
protein. This approach allowed us to identify a do- 
main of caldesmon containing the actin-binding 
site, the Ca2+-dependent calmodulin-binding site 
as well as the site responsible for the inhibition of 
actomyosin ATPase activity. It is located in the 
18 kDa polypeptide which is a product of further 
digestion of the 40 kDa fragment of caldesmon. 
The appearance of the latter fragment, in parallel 
with the high-molecular-mass fragments of 110 
and 80 kDa that do not affect actomyosin ATPase 
activity, after 1 min digestion suggests that it 
originates from a terminal part of caldesmon 
molecule. The 18 kDa polypeptide has a highly 
basic character since it does not bind to an anion- 
exchange column. Although the whole molecule of 
caldesmon is moderately acidic, it has a relatively 
high content of lysine and arginine residues [20] 
which are presumably concentrated in the 18 kDa 
fragment. Both the 40 and 18 kDa fragments 
possess the ATP-binding site as indicated by their 
binding to the Affi-Gel blue column as does the in- 
tact molecule. Hence, one can suppose that the 
phosphorylation site of caldesmon, important 
from the point of view of its function [20], is also 
located in the 18 kDa fragment. 
It has been shown that caldesmon is an integral 
constituent of smooth muscle thin filaments [21]. 
Its distribution on F-actin filaments is not known. 
It can be speculated that having elongated 
molecules with a tendency to form dimers [19,22], 
caldesmon can extend along actin filaments 
similarly to tropomyosin. The location of its actin- 
binding site in a relatively small domain (possibly 
at a terminal part of the molecule) could suggest 
that each caldesmon molecule binds to an actin 
filament at a specific point, possibly at a site where 
the ends of four tropomyosin molecules meet. This 
model would agree very well with the 
stoichiometry of actin monomer :tropomyosin :
caldesmon of 1: l/7 : l/28 in smooth muscle thin 
filaments [2I]. However, it does not explain how 
the effect of binding of one caldesmon molecule is 
transmitted along 28 actin monomers, especially in 
view of the present observation that inhibition of 
actomyosin ATPase by intact caldesmon and its 
small fragment is nearly equal. 
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